Molecular analysis of cyp51 from fluconazole-resistant Candida albicans strains

FEMS Microbiology Letters

Volumn 151, Issue 2, 1997, Pages 263-268

  Löffler, Jürgen ^a   Kelly, Steven L ^b   Hebart, Holger ^a   Schumacher, Ulrike ^c   Lass Flörl, Cornelia ^d   Einsele, Hermann ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Candida; Fluconazole; P450; Resistance

Indexed keywords

FLUCONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; DNA SEQUENCE; DRUG PROTEIN BINDING; DRUG SENSITIVITY; GENETIC POLYMORPHISM; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANTIFUNGAL AGENTS; BINDING SITES; CANDIDA ALBICANS; CYTOCHROME P-450 ENZYME SYSTEM; DRUG RESISTANCE, MICROBIAL; FLUCONAZOLE; OXIDOREDUCTASES; POLYMERASE CHAIN REACTION; STRUCTURE-ACTIVITY RELATIONSHIP;

CANDIDA; CANDIDA ALBICANS;

EID: 0343852970     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(97)00172-9     Document Type: Article

References (21)

1. Bates, J.H. (1986) Amphotericin B, amphotericin B methylester and other polyenes. In: Fungal Diseases of the Lung (G.A. Sarosi and S.F. Davies, Eds.), pp. 313-334. Grune and Stratton, Orlando, FL.
2. Saag, M.S. and Dismukes, W.E. (1988) Azole antifungal agents: emphasis on new triazoles. Antimicrob. Agents Chemother. 32, 1-8.
3. Van den Bossche, H., Willemsen, G., Cools, W., Marchial, P. and Lauwers, W. (1983) Hypothesis on the molecular basis of the antifungal activity of N-substituted imidazoles and triazoles. Biochem. Soc. Trans. 11, 665-667.
4. Vuffray, S., Durussel, C., Boerlin, P., Boerlin-Petzold, F., Bille, J., Glauser, M.P. and Chave, J.P. (1994) Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients. AIDS 8, 708-709.
5. Wingard, J.R., Merz, W.G., Rinaldi, M.G., Johnson, T.R., Karp, J.E. and Saral, R. (1991) Increase in Candida krusei infection among patients with bone marrow transplantations and neutropenia treated prophylactically with fluconazole. New Engl. J. Med. 325, 1274-1277.
6. Troillet, N., Duressel, C., Bille J., Glauser, M.P. and Chave, J.P. (1993) Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients. Eur. J. Clin. Microbiol. Inf. Dis. 12, 911-915.
7. Kelly, S.L., Lamb, D.C., Kelly, D.E., Loeffler, J. and Einsele, H. (1996) Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients. Lancet 348, 1523-1524.
8. Howell, S.A., Mallet, A.I. and Noble, W.C. (1990) A comparison of the sterol content of multiple isolates of the Candida albicans Darlington strain with other clinically azole-sensitive and resistant strains. J. Appl. Bacteriol. 69, 692-696.
9. Kelly, S.L., Lamb, D.C., Taylor, M., Corran, A.J., Baldwin, B.C. and Powderly, W.G. (1994) Resistance to amphotericin B associated with defective sterol 8,7-isomerase in a Cryptococcus neoformans strain from an AIDS patient. FEMS Microbiol. Lett. 122, 39-42.
10. Venkateswarlu, K., Denning, D.W., Manning, N.J. and Kelly, S.L. (1995) Resistance to fluconazole in Candida albicans from AIDS patients associated with decreased accumulation of drug. FEMS Microbiol. Lett. 131, 337-341.
11. Sanglard, D., Kuchler, K., Ischer, F., Pagani, J.L., Monod, M. and Bille, J. (1995) Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39, 2378-2386.
12. Van den Bossche, H., Marchial, P., Gorrens, J., Bellens, D., Moereels, H. and Janssen, P.A.J. (1990) Mutation in cytochrome P450 dependent 14 alpha-demethylase results in decreased affinity for azole antifungals. Biochem. Soc. Trans. 18, 56-59.
13. Lamb, D.C., Kelly, D.E., Manning, N.J. and Kelly, S.L. (1997) Reduced intracellular accumulation of azole antifungal results in resistance in Candida albicans isolate NCPF 3363. FEMS Microbiol. Lett. 147, 189-193.
14. Joseph-Horne, T., Hollomon, D., Loeffler, R.S.T. and Kelly S.L. (1995) Altered P450 activity associated with direct selection for fungal azole resistance. FEBS Lett. 374, 174-178.
15. Löffler, J., Schumacher, U., Hebart, H., Reitze, H. and Einsele, H. (1996) Extraction of fungal DNA from cultures and blood using the QIAmp Tissue kit. Qiagen News 4, 16-17.
16. Lai, M.H. and Kirsch, D.R. (1988) Nucleotide sequence of cytochrome P450 L1A1 (lanosterol 14-demethylase) from Candida albicans. Nucleic Acids Res. 17, 804.
17. Einsele, H., Steidle, M., Vallbracht, A., Saal, J.G., Ehninger, G. and Müller, C.A. (1991) Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction. Blood 77, 1104-1110.
18. Lamb, D.C., Kelly, D.E., Baldwin, B.C., Gozzo, F., Boscott, P., Richards, W.G. and Kelly, S.L. (1997) Differential inhibition of Candida albicans CYP51 with azole antifungal stereoisomers. FEMS Lett. (in press).
19. Kelly, S.L., Lamb, D.C., Kelly, D.E., Manning, N.J., Loeffler, J., Hebart, H., Schumacher, U., Einsele, H. (1997). Resistance to fluconazole and cross-resistance to Amphotericin B in Candida albicans from AIDS patients caused by defective sterol 5,6 desaturation. FEBS Lett. 400, 80-82.
20. Boscott, P.E. and Grant, G.H. (1994) Modeling cytochrome P450 14 alpha-demethylase (Candida albicans) from P450cam. J. Mol. Graph. 12, 185-192.
21. Fujii-Kuriyama, Y. and Gotoh, O. (1995) Molecular biology of cytochrome P450, evolution, structure and regulation. In: Molecular Aspects of Oxidative Drug Metabolising Enzymes (E. Arinc, E. Schenkman and E. Hodgson, Eds.), pp. 65-103. Springer Verlag, Berlin.